SENNA Syrup

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: SENNA Syrup
Generic name: SENNOSIDES A AND B
Manufacturer: SDA Laboratories, Inc.
Product type: HUMAN OTC DRUG
SPL set ID: cfc6ab2f-5376-46fc-ac58-7dedd7010006
SPL ID: 29bbb628-c28a-9fbe-e063-6294a90a7a8b
Version: 7
Effective date: 2024-12-20
Source export date: 2026-09-28
Source partition: 3
Source file: https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/fd09911bd1bc81f7f2faeb048e63855fe224e494376ae919a0035190e315c050/drug-label-0003-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:18:08

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M007	openfda.application_number
brand name		SENNA Syrup	openfda.brand_name
generic name		SENNOSIDES A AND B	openfda.generic_name
manufacturer name		SDA Laboratories, Inc.	openfda.manufacturer_name
ndc	package	66424-562-08	openfda.package_ndc
ndc	product	66424-562	openfda.product_ndc
ndc11	package	66424056208	derived:openfda.package_ndc
rxcui		702311	openfda.rxcui
spl id		29bbb628-c28a-9fbe-e063-6294a90a7a8b	id
spl set id		cfc6ab2f-5376-46fc-ac58-7dedd7010006	set_id
unii		1B5FPI42EN	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Do not use • laxative products for longer than 1 week unless directed by a doctor Ask a doctor or pharmacist before use if you have • stomach pain • nausea • vomiting • notice a sudden change in bowel movement that continues over a period of 2 weeks Stop use and ask a doctor if you have rectal bleeding or failure to have a bowel movement after use of laxative. These may indicate a serious condition If pregnant or breast-feeding, ask a health professional before use

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.